BridgeBio Pharma, Inc. ($BBIO)
Filing Information
| Accession Number | 0001470831-26-000635 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 24, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
19,887
Total Value
$458,701.56
P&L
+inf% (+$642,759.12)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 22, 2026 | Grant/Award | 3,990 | $0.00 | $0.00 | 11,455 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 22, 2026 | Exercise/Conversion | 2,808 | $41.73 | $117,177.84 | 14,263 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 22, 2026 | Sale | 2,808 | $68.00 | $190,944.00 | 11,455 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 23, 2026 | Sale | 2,196 | $68.57 | $150,579.72 | 9,259 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jun 22, 2026 | Grant/Award | 5,277 | $0.00 | $0.00 | 5,277 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jun 22, 2026 | Exercise/Conversion | 2,808 | $0.00 | $0.00 | 5,617 | Direct | โ | View Details |